Clementia: Ipsen closes $1bn Clementia Pharmaceuticals acquisition

Ipsen has completed an acquisition of Canada-based Clementia Pharmaceuticals to expand its rare diseases portfolio. The deal involves an initial...Read More...The post Ipsen closes $1bn Clementia Pharmaceuticals acquisition appeared first on Pharmaceutical Technology.